Angus G. Dalgleish

Angus G. Dalgleish

St. George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.

Journal: Oncology reports
Published: April 29, 2024

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy.

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy.

Journal: Frontiers in immunology
Published: October 09, 2022

Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope.

Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope.

Journal: Frontiers in oncology
Published: August 17, 2022

Naltrexone at low doses (LDN) and its relevance to cancer therapy.

Naltrexone at low doses (LDN) and its relevance to cancer therapy.

Journal: Expert review of anticancer therapy
Published: February 02, 2022

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients.

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients.

Journal: Oncology letters
Published: January 18, 2022

Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.

Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.

Journal: The Journal of general virology
Published: January 11, 2022

Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo.

Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo.

Journal: Oncology reports
Published: October 25, 2021

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.

Journal: Vaccines
Published: October 12, 2021

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.

Journal: Clinical and experimental immunology
Published: January 19, 2021

The immuno-oncological implications of insulin.

The immuno-oncological implications of insulin.

Journal: Life sciences
Published: August 21, 2020

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Journal: Oncology reports
Published: July 15, 2020

Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".

Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".

Journal: Frontiers in immunology
Published: May 20, 2020
Showing 1-12 of 78

Last Updated: 09/26/2026